ATMP - Current Trends, Opportunities and Hurdles in Production and Commercialization
ATMPs move between hospital exemption and industrial production. As a result, they also lie between the regulations: EU GMP Part IV and EU GMP Annex 1.
ATMPs expand the range of therapies enormously and can offer impressive results with solutions from the cell and gene therapy kits – right up to a complete cure.
Our seminar offers you an overview of the latest trends and works out suitable solutions in the Part IV/Annex 1 area of conflict.
Neben Impulsvorträgen, bieten wir Workshops an, in denen Ideen ausgetauscht und Kontakte geknüpft werden können. A guided tour of the Miltenyi company will round out the program.
Key Details
Target audiance
The event is aimed at students, experienced professionals and those responsible for hospital ATMP facilities.
Date
25.06.2026 5:00 pm – 26.06.2026 4:30pm
Location
Miltenyi Biotec
Friedrich-Ebert-Str. 68
51429 Bensberg
Germany
Language
German.
Workshop size
The number of participants is limited to 30 in order to ensure an efficient exchange.
Participation fee
The fees are per participant:
450,- € for ISPE members
750,- € for non-members – This booking option includes a one-year ISPE membership.
0,- € for student ISPE members – Memberships for students are free of charge. further information
Registration
Registration can only be done via the online form. Use the following button to go to the registration page

